320 filings
Page 3 of 16
8-K
ryopv7izhoicsq6y
14 May 21
Departure of Directors or Certain Officers
5:20pm
8-K
z2zyp2dlvcueo08dwuk
13 May 21
Departure of Directors or Certain Officers
5:15pm
8-K
y0mig7 0iui31f65d
10 May 21
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights
4:20pm
8-K
s0pp1
11 Mar 21
Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
4:20pm
8-K
8fkafxij
5 Feb 21
Departure of Directors or Certain Officers
4:45pm
8-K
2tfrgqsl5 2bak4909
8 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
a87tna8yw
5 Nov 20
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
4:32pm
8-K
3mh yjkqmybd89w2
1 Oct 20
Entry into a Material Definitive Agreement
5:00pm
8-K
hmn ey67hz5iwdzesq
4 Sep 20
Entry into a Material Definitive Agreement
4:30pm
8-K
93n14bqfc dkh
6 Aug 20
Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events
4:15pm
8-K
az7pkisbcpb6j12m7x
9 Jun 20
Departure of Directors or Certain Officers
5:28pm
8-K
1wy4ty rarxgs0ovb
28 May 20
Geron Corporation Reports First Quarter 2020 Financial Results
4:15pm
8-K
fhn8hk
26 May 20
Entry into a Material Definitive Agreement
5:00pm
8-K
cbj3sudi
21 May 20
Other Events
4:01pm
8-K
bki3l g4hzs3pve4oby8
8 May 20
Other Events
5:15pm
8-K
pxkzki
2 Apr 20
Geron Provides COVID-19 Related Business Update
8:30am
8-K
eji6cdu0rwzh ra6e6ip
12 Mar 20
Geron Corporation Reports Fourth Quarter and Full Year 2019 Financial Results and 2020 Milestones
4:20pm
8-K
580q f51hjlls2jt
14 Feb 20
Departure of Directors or Certain Officers
5:15pm
8-K
ifg3d 02cdqbqhkvd2tq
13 Jan 20
Results of Operations and Financial Condition
8:05am
8-K
4hpauz o3ip2kn
18 Dec 19
Geron Conducts End of Phase 2 Meeting for Imetelstat in Relapsed/Refractory Myelofibrosis
5:20pm